Home

【はじめに】新生児の上気道は構造的に

1. 1 5 2 Guven
2. ll HI 408 O 341 2 2 2010 3 10 23
3. 100 1 A B C D 2 E F G
4. 2002 2 2010 6 59 K 2001 DQ DQ 80 60 12 4 3 2 2 Dandy Walker Synd 1 22 47 12 10 6 TA 1 4 4
5. NCPR O 368 NCPR
6. 381 O 235 3 E 2003 1 2007 12 NICU 35 3
7. 2000 2007 FGR 94 EFW EFW Z UA MCA 47 2 O 335 SGA
8. 1 39 2 2 26 2 32 2 5cm 4cm 37 0 1784g 2878g
9. NICU 18 15 100Hz Y Y 37 6 1 8 2 78 1 51 34 8 0 8 Y
10. 1996 1 2008 12 13 NICU ELBWI360 12 ELBWI 60 60 2 3 IVH PVL NDI 483 4802 3 54 11 2 451 9 4 222 46 0 1477 30 8 3 3
11. O 244 2 ARB 2 2 ARB 2 3 ARB 2 ARB 2 1 33 G2P1 32
12. O 236
13. 2000 2009 B polymyxin B immobilized fiber column direct hemoperfusion PMX DHP 8 1 P F AaDOz 12 24 36 SteeLDwass 38 39 31 7 2922743g
14. 3 4 4 1 38 2 2800g Apgar score 9 10 Pierre Robin sequence 2 39 5 2820g Apgar score 10 10 3 39 6 2344g Apgar score 9 9 4 26 6 991g Apgar score5 7
15. 40 Ia MPA MPA 2001 1 MPA 12 15 34 0 2 8 35 9 IVF 13 5 1 1 IVE 2 12 22
16. O 298 H1N1 2009 HI1N1 2009 H1N1 2009 11 H1N1 H1N1 HI1N1 2009 HI1N1
17. BNP 33 2 14 15 6 9cm 1 1 64 6 0
18. VTE 2006 1 2010 12 29 2 37 S 14 C 3 3 ATIII 1
19. 2010 1 12 8 3 18 3 1 1 IFN7 ILlb IL 3 IL 4 IL 5 IL 6 IL 8 IL 10 IFN7 IL1b IL 10 Neonatal transient eosinophilic colitis NTBC IL 3 IL 4 IL 5 IL 6 IL 8 7 NTEC IL 3 IL 4 IL 5
20. 47 2 O 359 NO NO lt HFO gt HFO NO NO HFO V amp reg V X amp reg X amp reg VENT MAP 10 30cmHzO Stroke volume SV 10 160ml NO NO 20ppm NO VENT NOxbox
21. 379 O 227 SGA small for gestational age 3 5 2 2 9 SGA SGA 1981 10 2008 12 37 2 0SD SGA 2
22. 2 14 35 16 PIH5 8 2 4 SRA 509 vs40 47 vs31 SRA index PIH1 6 SRA index 12 SRA Du ll HI 388 O 261
23. 2010 5 12 251 CTG 2009 9 2010 4 249 60 10 pH PaOz BE Apgar Score 10 3 4 p 0 001 Apgar Score pH pH pH p 0 018 4 5 3
24. CAM pretermPROM pPROM pPROM CAM 2009 1 2010 12 pPROM 24 33 35 CAM 17 CAM 18 CRP WBC i Mann Whitney U 2 p 0 05 CAM WBC 15761vs10138 L CRP 2 50vs0 82mg dl 35 3vs5 6 37 3vs37 1C 27 3vs28 8 1096vs1246g
25. 2010 Bayley 2010 2011 18 3 28 29 6 1269 5g DQ 102 0 94 6 105 0 DQ 91 3
26. CLD 9 2007 1 2010 9 9 48 CLD 24 26 6 908g 59 HOT4 non CLD 24 28 6 1062g 5 CVC Crs 9 VC 1 FEV1 0 9 WISC CLD CVC 22 4ml kg Crs 1 2ml cmHz0 kg non CLD CVC 22 6ml kg Crs 1 2ml cmHz0 kg 9 VC CLD 84 9 non CLD 97 3 FEV1 0 CLD 98 2 non CLD 100 5 CLD VC CLD 124 4cm non CLD 125cm CLD 22 9kg non
27. PHA ALD ALD Na KK PHA 2 Na K PHA 4 1 36 3 2464g 1 Na 136mEq L K 8 0mEq L GI 1 gt 20ng ml hr ALD 3680pg ml 2 30 0 1656g 21 1 Na 132mEq L K 7 4mEq L GI 2 gt 20ng ml hr ALD 4127pg ml 3 37 5 2735g
28. 30 ll HI 410 O 349 12 13 2 1
29. O 262 2 12 2 9 9 9 1 22 11 2 189 GP 7
30. NN HN 376 O 213 2 3 9 LPS 16 LPS LPS LPS 1
31. O 308 18F fluoro L DOPA PET 18F fiuoro L DOPA FDOPA PET 17 17 FDOPA SUV SUV 100 SUV 70 SUV 2 5
32. Key age 10 3 Ii 47 2 O 239 3
33. 411 O 355 20 3 1 2 A B C
34. 1 HI 386 O 253 12 12 10 2 19 36 11 17 42 3 1 6 2 J
35. 2000 2007 FGR i 3 61 i 1539 187 12 AGA 70 SGA 83 t 2 p lt 0 05 Hb SGA
36. 1999 1 2010 12 12 1 470 27 15 12 20 7 13 12 2 16 5 3 3 O 350 NICU 35
37. NN HN 382 O 237 MRI PVL MRI 2002 4 2007 7 MRI PVL 51 18 K 32 MRI 18 MRI K 30 3
38. 30 behavioral states FGR 1 5SD FGR20 19 30 37 NST FGR 54 46 10 2 0 5mm 1 30 31 2 32 33 3 34 35 4 36 37 FGR FGR 36 2 1719g 37 0 2700g
39. TRS 20 TRS 20 28 11 47 6 56 1M 64 8 69 8 TRS 20
40. 24 5 29 0C ii HI 414 O 365 NCPR 2005 1 2 2009 1
41. 2011 23 6 O 329 2 3 9 9 3 9 7 IUGR 14 34 GCC MS 18 1 9c C18 18 1t C18 18 1t 18 1 9c ug g
42. O 268 lt IL 6 8 2005 1 2010 12 14 15mm AFI 30
43. O 214 LPS 2 3 5 2 9 CAM CAM LPS CAM 20 SD LPSO0 1g
44. NOx 2009 7 2011 1 32 49 35 27 6 2 5 1018 343g Amicon Ultra 4 Centrifugal filter Unit NOx NOs NOs Assay KitC2 Colorimetric Griess VL2 NOz NOs 5 0mol L 2739 7 mol L 450 mol L NOx Cr 0 49mmo1 mmol NOx Cr 5 29
45. 2 9 VGCV CMV CMV VGCV VGCV 2009 10 NICU CMV 7 VGCV 8 16mg kg 1 2 6 CMV DNA ABR VGCV 11 4 105 CMV DNA 5 71 CMV DNA 6 86 7 2 2
46. 1 O 272 18 2 3 18 T18 TCD APCD
47. 30 1 2007 lfe threatening events 2 S TA ABPC CTX ABPC GM 3 2010 12 S TA
48. 2006 300 35 2008 1 1 2010 12 31 NICU 1013 35 29 863 456 407 2 81 6 19 54 3 58 8 52 40 8 36 6 3 0 0 9 2925g 2687g 28 5 16 4 23
49. O 352 1 2 3 3 BegumEsmot Ara NICU 1984
50. n 49 n 24 2 8 3 NRFS n 25 5 20 pH informed consent O 340 JA
51. SpOz 8 24 NICU i
52. BNP O 260 scavenger receptor A scavenger receptor A SRA 1 SRA 2 1 SRA
53. C SP C 0 40 3 3240g 3 SpO gt 60 FiOz40 SpOz90 X SP A SP D KL 6 CT GM CSF SP C SP C 88 178
54. 2005 5 2869 CLD 76 2 7 3 6 CLD 17 0 6 2 2 HOT 4 0 14 0 4 CLD CLD 30 1500g CLD 1 7 CLD Lung protective strategy FT 47 2 O 207 2
55. 47 2 O 319 NICU Infection Control Doctor MRSA NICU MRSA NICU Infection Control Doctor ICD NICU18 GCU20 NICU 2007 6 1 2007 9 MRSA
56. TTN 2005 5 2 500g TTN 146 N DPAP A 75 B 71 1 2 324 1 220 2 500g 882 243 TTN 146 60 2 A 37 4 B 38 6 A 2 842g B 2 920g 3 A 58 77 B 41 58 A 4 Retraction score A 4 9 B 2 7 A 1 3 B 0 6 A 5 A 41 B 26 A
57. 407 O 339 4 104 36 00 2 2414 5 302 6g 70 2 1 0 96 AS6 8 UApH7 205
58. PIH IUGR mTOR 4 PH 3 IUGR 3 IUGR system L LAT1 LAT1 mTOR LAT1 PIH IUGR syncytiotrophoblast PIH IUGR mTOR PIH IUGR syncytiotrophoblast PIH IUGR
59. 47 2 0 367 Consensus 2010
60. 2005 NCPR2010 2 O 366 Mongolian NRP 2 2008 MNRP MNRP 2008 2009
61. O 358 Co medical 2 3 2 9 3 2009 4
62. O 212 LPS 1 2 3 5 2 9 LPS SD 20 2 0 1mL 0 1g LPS 0 1mL
63. 3624 44 37 8 86 700 6 50 24 13 9 9 8 8 lt 3 1 0 3
64. 25 6 1 8 806 154g 25 81 6 798 206g 3 vs 91 6vs 97 10 p 0 16 90 10vs 94 10 p 0 36 84 16vs 94 16 p 0 15 SD NPR NPR NPR NPR li HN 380 O 229 NICU
65. r 0 34 p 0 073 DQ 1 O 240 VLBW lt VLBW
66. Trisomy18 100 4 trisomy18 17 trisomy18 Trisomy18 17 17 16 2 trisomy18 28 8 19 33 FGR17 17 100 2 4SD 12 17 71 17 17 100
67. CMV CMV IgM CMV DNA CMV CCMV 1000 1500 CCMV 26 4 1 1
68. CPAP O 198 NPPV CCHS 1 2 CCHS POX2p NPPV NPPV NPPV CCHS 1 33 2 2 1 CCHS NPPV
69. 4 0SD 500g extremely severe FGR ES FGR We 1994 2010 ES FGR10 1 1 1998 K 2001 28 1 439g 6 4 2 4 1035 DQ Developmental Quotient 90 5 3 1 6 DQ 3 1 1 1 4 1
70. 2010 10 5 VLBWI 20C CMV DNA QIAamp amp reg DNA Mini Kit QIAGEN real time PCR gH 4 2 CMV DNA 2 4 5 1540 2021 copies mL 2 500 copies mL 1 CMV O 316 2
71. O 278 2008 2010 1 3 III IVP CT 2008 2010 34 10mm
72. 0 HI 384 O 245 20 1 Upshaw Schulman TTP Von Willebrand factor VWF ADAMTS 13 ADAMTS 13 Upshaw Schulman 23 0GOP ITP 20 3 20 5
73. 2010 1 2010 187 60 32 13 12 12 12 8 8 17 9 28 37 8 2 3 2760 511g 85 45 20 65 6 11 6 5 ductal shock 158 84 24
74. 2010 7 120 1 Iml
75. 32 30 fh 47 2 O 247 4 500 1000 1 PIH PIH 1 43 1 25 1
76. CAM TFLX LVEX 8 3 36 13 4 36 13 4 36 CAM 3 GBS 44 401 O 315 CMV CMV VLBWI CMV CMV CMV CMV CMV DNA
77. 2011 23 6 O 241 ECMO ARDS 1 2 2 ARDS ECMO 1 21 0 0 29 3 29 6 X 30 0
78. O 312 CMV 2 2 TORCH 1 CMV 300 1 2 1 1 39 2 3 192g 37 38 CMV IgM 0 46 0 80
79. O 276 21 2 D 9 21 1996 1 2010 12 15 21 21 29 21 33 21 9 8 2 X 2 1
80. 2 3 2 2 3 TAS NN lt primary endpoint gt 28 lt gt 1 18 0 33 6 2 7 3
81. 7 FT 375 O 211 1 2 9 CLD ICR 85 RA 14 RA 7
82. COX NF xB O 210 G CSF IL G CSF G CSF
83. 6 157 37 41 100 34 36 29 31 33 14 28 30 7 25 27 7 5 4 100mcl LCMSMS 14 Cortisol F Cortisone E E F 170HPresnenorone 17OHP 170HP 17OHPresnenolone 170HP 5 Mann Whitney U 4 vital sign E F E F 5 170Hpregnenolone 17OHP 170HP 17OHPregnenolone 17OHP 3 HSD 170HP
84. 30 RM 1 7 31 Sp0z 3 2 WBC23000 mcl CRP 10 80 PCR a 35 CAM 8 2 23 0 658g 40 1
85. 24 4 1 80 85 21 23 G CSF0 5 g g 5 2 80 85 21 3 23 G CSF0 5 g g 5 4 23 6 HE PCNA cg SMA G CSF G CSF G CSF
86. CPR 2 C small for gestational age SGA SGA SGGA SGGA SGA 45 SGA 22 SGA 23 SGA 9 4 5 2 1 4 3 BML SGA 2 147 364g vs SGA 2 066 345g CPR SGA SGGA
87. 2 19 1 2 1
88. 1 2 2 O 354 1 1 17
89. 2 200 STIC 3 STIC 393 O 283 2004 II 2004 10 1 II 8307
90. lt O 284 1 2 2 2000 2 P 48 Fp 29 Np 19 S 61 F s 20 N s 41 P 4ch 26 34 4ch 3 14 SpOz
91. amp reg SV NO X HFO VENT 70cmHzO 1 V NO 2 X 10L SV 80ml NO MAP30cmHzO 20L MAP 20cmHzO 3 X NO P lt 0 05 12 5 89 50 100
92. T ml O 228 3 NPR NPR NPR NPR 3 2005 NPR 3 7 NPR 19 3
93. amp reg 15 7 3 5 4 11 Pfannenstiel 13 14cm 2 4cm 21 Pfannenstiel
94. 2486g off set 7mm m 19 25 STIC Y X STIC secound opinion O 282 STIC 1 1 500
95. 2 2 2 9 5 5m 16 m HuBDIC Global Pro FS 300 25C V2100G 30C 50 25 10cm 10cm 54 6 lt 10cm 1C
96. 28 PPROM 3 2006 1 2008 12 28 PPROM 3 K 85 85 3 2 1 Mann whitney U p lt 0 05 39 28 72 11 28 24 0 vs 24 0 22 vs 11 27 8 vs 26 7 961 vs 870g CAM
97. IL 6 8 AMY y GTP ALP LAP 2 IL 6 8 lt ALP LAP 14 IL 6 8 PIN i ee i ll 390 O 269 microRNA 2 2
98. 2 microRNA miRNA miRNA miRNA 10 20 miRNA miRNA 14 6 10 20 real time PCR
99. 2009 11 19 2010 1 8H 1 267 H1N1 211 286 H1N1 pH H1N1 2009
100. A H1N1pdm A H1N1 pdm 2010 6 10 40 H3 uptake A H1N1pdm IgG A M A H1N1 HA EIA 1 LST H3uptake 553 2561cpm S I 356 1211n 9 2 IsG A M IgG IgM A 4 IgG
101. PIH PIH 0
102. non reassuring fetal heart rate FHR pattern 1998 2003 65197 population based 34 46 13 13 13 CP 11 MR 2 2 11 6 55 reassuring pattern Non reassuring pattern 5 459 ate deceleration 4 variable deceleration 2 non reassuring 3 1 1 reassuring pH pH 7
103. 32 2006 1 2011 1 32 55 1cm 1 2cm 2cm 3 1cm 1 2cm 2cm 23 17 15 26 6 19 4 31 4 28 4 24 0 31 9 27 4 22 7 31 9 12 70 19 2 41 8 0 62 Dry lung CLD3 cystc PVL 2 IVH 1cm 11 1 2cm 5 2cm 1 3 1cm 23 24
104. mT O 248 SS A SS A 1 2 complete heart block CHB PR FGR PSL CHB study PSL
105. 47 2 O 199 CMV HF 3 IMV HFV CMV HF babylog 8000 CMV HF 1 24 6 319g SIMV 21 HEFV CMV HF pCOs 2 22 5 495g SIMV
106. 2 3 22 24 A 25 27 B 10 10 4
107. 35 7 19 70 3 5 18 5 1 3 12 48 0 1 4 12 2004 1 2010 12 41 BNP 24 TOF 8 VSD 3 ASD 2 11 BNP pg ml BNP 3211 36 18 51 23 54 38 31 16 BNP BNP
108. CDH ECMO CDH CDH 1985 2010 40 Bochdalek L T Apgar score 1 Xp 4 10 28 70 29 18 39 9 38 26 44 2796 1115 3730 g 29 11 Apgar score1 5 0 9 Xp 10 7 NO 19 47 5 ECMO 8 20 32 5
109. A S gt MNRP 7983 8909 2008 2009 94 1 93 1 A S1 0 3 2 38 1 21 A S5 7 10 94 7 96 7 A S1 0 3 14 0 29 4 A S 2008 2009 A S 2010 2010 NRP MNRP A S
110. 2 3 29 B GBS GBS GBS CDC 2001 GBS GBS AMPC 30mg kg day 3 GBS 2001 1 2010 12 10 7 356 1
111. Northway BPD post surfactant era BPD less fibrosis fibrosis BPD fbrosis C ECM 2 ECM myofibroblast MP BAL C BPD fibrosis 20 22 7 30 50 36 Co N 23 N 27 1 7 14 C
112. MRI 14 O 258 27 H21 4 H22 4 27
113. 47 2 O 271 2 2 10 12 2001 1 2011 3 53 36
114. O 320 1 2 1 1 2002 10 1 2 33 3 33 34 35 RS 5 NICU 7 RS RA
115. 25 33 20 1 1 2D three vessel tracheal view STIC inversion mode 3D Voluson E8 Expert 2D 20 15 3D 5 3D 3D i STIC ii 3D
116. 1 37 7 309 70 130 7 7 1 33 2 43 3 31 39 11 7 1239 34 37 7 100 38 5 280m1l 1 7 89 2580g Apgar score 8 8 7 7
117. Trans umbilical approach CDH sliding skin window Alexis Wound Retractor XS Applied Medical 1 CDH L T 0 25 A 1cm 3x1cm 20 2 CDH L T 0 14 16 A 1cm 2x1cm 19 CDH Trans umbilical ap
118. VLBWI 152 LT4 20 13 2 26 82 9 941 243g 3 IVH 2 10 PVL 4 20 LT4 23 5 58 1 5 40 LT4 3 15 25 25 8 DQ 89 9 15 9 LT4 FT4 46 36 9 8 3 DQ90 4 17 7 FT4 58 37 1 7 7 DQ94 6 14 6 VLBWI FT4 LT4 RCT LT4
119. 37 4C JCS 200 1 6 I Hb 5 4g dl FFP ADAMTS 13 TTP Upshaw Schulman ADAMTS 13 ADAMTS 13 O 246 1
120. 29 718 gt 700 I 40 78 51 37 73 15 29 1 749 1 693 24 356 CLD O 306 3 1
121. 1 2 MAP20cmHzO SV80ml 2 SV O 360 2 2 NO 2010 8 NO NO 4 4 1 V 2 SLE5000 3 PB840 4 Servoi
122. 45 2 1 1 32 6 12 19 36 1 4 2 21 3 11 9 3 2 4 3 5 4 3 1 82 6 47 NCPR IBCLC 5 45 6 1 11
123. 5 39 147 3 1 x Fisher Student t 0 05 46 2 vs 13 6 Apgar score lt 0 01 3 22 95 1 30 7 96
124. 1 34 32
125. 1400mg 1200mg 140mg 13 1 25 32 34 39 2 2056g Apgar score 8 1 8 5 PDA VSD ASD 13 89 3 3kg
126. 2011 23 6 O 289 11 CDH 2004 9 2011 2 11 CDH 32 1 25 40 30 4 22 35 37 3 34 6 40 5 10 91 2 9 18 1 81 9 10 91 0 1 9 0 8 72 3
127. 6 9 FVC 100 FEV1 94 MMF 65 PEF 88 MEF50 82 MEF25 82 76 170 45 52 50 28 28 8 O 204 9
128. 2 NICU PI 2010 3 1 2011 2 28 NICU GCU PI 600 PI 202 132 PI 10 103 62 99 42
129. 3 9 1 500g NICU CLD CLD 2003 1 2010 12 NICU 1 500g Eh a 313 274 2003 41 5H 50 33 5 2010 18 2 10 30 6
130. 3986 16 0 4 12 4 3 13 4 1 2 1 3 10 13 9 45 5 8 1 2 MMIHS 5 VUR 0 49 81 31 33 3 2005
131. 20 T10 3 E2 43 7 399 O 307 1IGF IGE I Insulin like growth factor I IGEF I 1994 2010
132. HTO CV severe IVH cystic PVL HFO volume expander HFO T O 202 2010 11 2011 3
133. sLLS HC O 218 RIAC 32 33 ganglionic eminence GE RIAC 2006 1 2010 12 5 NICU 33 RIAC Sp0 lt
134. 4mg 36 0 ARB 36 2 2614g APS 5 6 5Cr 6 82mg dl 4 2 28 GOPO 4mg 29 ARB 32 6 1842g APS5 9 0 2 3 2
135. 21 20 16 76 19 15 71 4 1 75 O 294
136. lt gt 20 2 2008 3 2010 3 24 1 17 70 8 ee 27 20 32 34 28 40 19 23 82 6 12 16 759 PR 16 7 34 PROM5 24 20 8 Mirror 3 PIH1 TAS 389 O 267 100
137. 1 SRA index 10 high power fields SRA 30 34 35 73 3 128 80 857 5 37 8 24 2 SRA index 5 20 450g 1420g 2 3 cesarean hysterectomy 5cm 10cm cesarean hysterectomy baloon occlusion
138. 1153g Apgar score4 1 4 5 NICU ARDS ECMO 1 9 ECMO 15 PCR ARDS DECMO ARDS ARDS PCMO O 242 Common variable im
139. 2 47 2 O 303 2 3 2 2 GC GR
140. 1 1 25mg d 82g 203ml O 264 3 3 3D MRI 2 2D 3D
141. O 254 4 1 2 3 PIH 4 4
142. 1992 7 1 2010 12 31 18 1 1703 66 2 41 1 17 1 0 68 5 29 4 7 41 2 27 1 6 70 130 3 8 28 6 6 35 3 5 18 5
143. ECMO CDH2 CDH19 A 13 B 6 MGL 4 AaDOz OI ECMO Mann Whitney U Fisher p 0 05 MGI 10 A 6 B 4 A 1 18 B 0 87 B p 0 014 1 0 759 1000 p 0 033 OI 8 B AaDOs 8 OI 35 83 3 100 p 0 0005 CDH MGI 8 OI
144. LCC LCC 2006 6 2008 3 32 86 23 31 410 1141g 19 1 2 100 GCMS precursor 33 34 35 36 27 28 precursor 33 34 3 HSD 31 34 3 HSD 32 34 LCC
145. P lt 001 CLD 60 30 1 PVL PEEP 4 6cmHzO Tidal volume 5 6ml kg nasal CPAP nasal CPAP 6 7cmHzO SiPAP CLD O 208 BAL C 1 2 DepartmentofPediatrics SeoulNationalUniversityCollegeofMedicine
146. 2010 10 37 42 Bishop score 6 214 A 2010 11 Bishop score 6 89 B Bishop score A 2 7 1 3 B 3 7 1 8 A 416 332 B 479 399 B 29 A 2231 B 1530 A Bishop score 2 7 6 3 A 9 8 B 4 59 NRFS UApH lt 7 200 NICU A
147. 44 vs 1 60vs 2 14 2 02 p 0 05 1 43 p 0 06 0 07 34 2vs52 0 p 0 01
148. TCD APCD 2011 23 6 O 273 1220 2009 4 2010 12 21 1220 Voluson E8 Expert 2D 18 PTC 15cm 20 PTC 20cm 18 PTC
149. 0 3 4 1 2 K 1 2 2 2 25 1 2 3D 4D STIC 1 3D 4D STIC 24 3D 4D STIC
150. NICU UA MCA 94 10 119 5 5 109 38 0 2 10 2 3 10 6 0 7 66 7 0 VS 5 89 8 9 VS 2 1 p 0 05
151. 1 200 1 2 sentinel event O 348 187 2 2
152. 30 O 232 PIH SS A B 2009 1 2010 12 2 25 ANA SS A SS B
153. CDH 2002 3 2011 2 FETO 30 CDH17 28 30 GO G1 G2 G3 90 Survival Rate SR 6 Intact Discharge ID CDH17 SR ID 52 9 41 2 G3 9 G0 2 8 NN ID G3 22 2 2 9 11 1 1 9 GO 2 77 8 7 8 75 0 6 8 CDH G3 FETO O 266
154. 1 34 38 1 34 5 422g 1005g 37 4 2665g 5 4 2 CD UC CD UC CD
155. 286 250 IRI CPR IGF I HFD 2 250 39 3 3197g 1 63 2 50 137 CPR CPR 2 lt IGF I HFD 25 AFD 14 SFD 1 HFD IGF CPR IGF I IGF I HED
156. HbA1c 1 2 HOMA 1 4 I Index 2 3 2 3 4 GDM 3000g 2008 2010 1247 948 143 81
157. 7 1 2 4 5 95 95 2 NCPR 4 ALSO 2 150 92 ll HI 412 O 357
158. 2 2 2 47 2 O 263 JA 120 TRS 20
159. 20 PTC 18 18 30 1220 30 4 0 3 1 2 O 274 13 18 21 45X
160. 2011 3 NICU GCU DPT 0 2ml 14 NICU GCU 38 52 DPT 0 2ml 7 7 4 52 15 4 8 52 5 8 3 52 3 8 2 52 1 52 3 DPT DPT DPT 0 2ml Mk 15 ei
161. 25 SLE 14 3 4 SLE 3 3 1 17 PSL 4 2 PIH4 2 1 1 25 GA 39 4 0 3 4 BBW 2726 464g ANA 24 23 96 SS A 14 12 85 SS B 3 1 2 2 3 2 SS B 2011 23 6 O 233 pretermPROM CAM
162. 47 2 O 255 2005 9 14 36 4 3 08 2 25 8 1 8 2 2 7 5 2 7 36 8 31 40 1 6
163. 9 Na 132mEq L K 6 2mEq L NaCl 5 gt 20ng m1l hr ALD 8990pg ml 4 34 2 1965g 1 Na 130mEq L K 6 2mEq L NaCl 1 gt 20ng ml hr ALD 16000pg ml PHA NR3C2 4 ALD PHA Na K O 310 NO NOz NO0s NO NO
164. 1 FGR 2 7 0 5 vs 3 5 0 9 p 0 088 3 4 1 FGR 1 0 0 7 vs 1 80 9 p 0 047 3 4 FGR 4 O 344 1 2 2 2 2
165. Na Na 2005 10 2010 3 NICU LCD 9 12 LCD A 6 B 7 Na Na A B A A Na B Na B 28 31 lt LCD Na LCD Na
166. NCPR 2 2 2 D D D NCPR 20 I 12 NCPR A B J B A 20 3 21 6 22 5 240
167. 39 40C 37C uw 413 O 363 SiPAP 2 SiPAP SiPAP MR730 Fisher amp Paykel
168. 2011 23 6 O 353 H NICU 2 500 NICU 3 GCU 4 10 16 5 2 1 14 9 16 8 16 9 21 3 1
169. GDM turkey 2 X NGT284 GDM GDM 60 GDM GDM 17 OD15 HRGDM5 NGT39 0 1 8 meanSD GDM38 GDM38 8 1 3 OD36 5 5 3 HRGDM39 0 1 8 OD D 0 0001 BMI NGT21 84 0 GDM24 8 6 3 GDM26 4 6 1 OD28 3 6 7 HRGDM33 5 5 6 p 0 001 BMI 25 7 3 9 OD29 8 7 3 HRGDM34 3 2 7 p 0 0001 NGT HGDM OD p 0 0162 p 0 00024 NICU GDM p 0 01472 OD p 0 01632 OD p lt 0 0001 Ne ll 404 O 325
170. 22 2 4 8 10cmHz0 LPS 58 vs 15 jp 0 01 LPS 2 0 71 0 02 vs 0 64 0 02 p 0 05 8 50 150 m 8 3 1 1 vs 5 4 0 7 p 0 05 0 1 rg LPS LPS LPS
171. Hb AGA SGA SGA AGA il O 336 40ml
172. Na Na LCD ll HI 398 O 301 2 LCC GCMS 3 hydroxysteroid dehydrogenase 3 HSD
173. 5285 3 3 K DQ lt 70 4 47 2 O 223 population based study Sa B 3 3 2005 2009 Mann Whitney U test Kaplan Meier 50 632 197 2 Trisomy18 195 40 21
174. 2 small for gestational age SGA appropriate for gestational age AGA SGA SGA 2008 2010 AGA SGA SGA AFD 2 Z 1 5SD UA RI MCA RI PSV pH 7 15
175. 7 G TP O 292 22 ELBW 2000 2010 11 ELBW 1 5mg d1 22 ELBW 12 9 171 22 26 6 23 1 31 2 688 5g 458 974 11 50 AFD
176. SS A PSL PSL CHB SS A 2000 1 2010 12 59 50 PSL CHB 39 19 ITP1 PSL 36 CHB PSL 23 1 CHB PSL CHB 2011 23 6 O 249
177. 0 920 58ng ml vs 0 62 0 24ng ml p 0 05 SGGA 46 0 3 1cm vs 44 0 3 2cm Ponderal Index 2 20 0 17vs 2 44 0 38 C malnutrition normal small 405 O 331 mTOR 2 2 2 AskewDaved 9 TUGR PIH PIH IUGR 30
178. LCW 11 3182g AP9 9 2 28 37 5 NST prolonged deceleration 4 LCW 8 2996g AP8 9 LCW 4 3 67 1576 NST 3 1 CTG 64 2 CTG 0 LCW deceleration 58 2 1 LCW 15 6 oxytocin Fetal deceleration LCW 30 LCW LCW 1 deceleration 47 2 O 343
179. NICU CLD CLD O 206 CLD 2000 Lung protective strategy to prevent hyperoxemia SpOz lt 91 permissive hypercapnea PTV 2005 1 1 2009 12 31H 5 EE CLD 28 CLD CLD 36 CD HOT
180. 313 1184 322g 18 1t 18 1 9c 2 6 0 8 18 1t19 77 5 g g 18 1 9c 784 350 g g 31 33 11 IUGR5 18 1t 18 1 SD R 0 89 P 0 017 SD R 0 95 P 0 004 SD R 0 97 P 0 001 18 1t SD R 0 82 P 0 046 19 1 N 15 N 4 18 1 21 0 8 3vs12 3 2 8 P 0 058 O 330 C C CPR
181. 37 2009 1 2010 12 2 37 345 266 79 132 Z Z 1 UA MCA Z 1 5SD FGR 3 K DQ 70 p lt 0 05 700g 600g 26 27 27 UA MCA Z
182. 5 09 2 8 VS 8 49 5 1 p lt 0 05 4 94 5 6 7 11 6 3 2011 23 6 O 337 PROM 2 9 37 Bishop Score
183. HFV CMV HF pCOs 3 39 4 0 1 1 5 3 10 SIMV 3 HFV CMV HF CMV HEF HFV HFV O 200 4
184. 12 PET 6 17 3 PET PET 2 ll HI 400 O 309 4
185. 13 3 IIIA 7 25 9 4 5 AFD 7 2 1 2 HPV DNA 3 HPV DNA high risk follow up low risk O 252 6 57 Crohn Disease CD Ulcerative
186. 27 LT4 4 2 TB12 2mg dl DB8 5mg dl 7 GTP82 IU I 3 2 29 3 1124g 22 LT4 2 GH 3 8 TB13 6mg qdl DB9 2mg dL 7 GTP50IU I 9 3 41 0 3442g 1 LT4 GH 1 TB21 6mg dL DB14 4mg dl 7 GTP148IU 1 4 4 41 3 2770g Apgar5 9 6 LT4 19 1 TB20 0mg d DB13 1mg d1 7 GTP295IU I 2 1
187. mTOR O 332 Light for date infant TLight for date infant LFD resistance index RI LFD LFD 2007 4 2010 3 3
188. 377 O 219 2003 2005 3 28 2 3 5 9 3 9 28 3 2003 2005 5285 22 27 2016 4 K DQ 70 22 23 24 25 26 27 75 245 332 405 482 477 4
189. 3 9 2 9 9 VLBW 3 MA NS UN 3 0 1 3 Nd 2 3 K oo 3 te Staview5 0 2 t 2404 1717 687 1 NDI 317 18 5 109 15 9 CP 113 45 6 6 K MR 270 15 7 86 12 5 2 3
190. 4 2 NRFS 4 2 2 1 FGR O 256
191. 5 12318 251 251 85 4 50 A 23 B 14 C 13 A 18 50 12 50 40 1 C A 23 10 10 3 B 14 10 C 13 Noonan 7 1 18 A 26 B 67 C 23 18
192. 6 A B A 7 A 37 49 N DPAP N DPAP 32 8 A 10 B 7 38 Retraction score 40 O 216 C SP C 1 1 2 D D 2
193. 88 37 102 B 21 6 192 I 1 J 8 lt B 22 1 27 I 1 6 22 1 1 NCPR NCPR 1 B
194. PIH 230 120mmHg 4 9g dl 13 2g 2 37 2 1 3 B g 30 4 9g dl 3 3g 3 26 0 1 3 B PIH 31 4 5g dl 6 6g 4 29 0 31 0 31 6 4 4g d1 4 PIH 3 3 PIH 5 0g d1
195. hydroxychloroquine X 2011 23 6 O 217 Leaky Lung Syndrome 1 2 MV LLS sLLS TAF
196. lt 7 1 2005 270 57 507 36 465 37 2009 1 605 66 703 2 4 708 83 179 0 8 24 5 765 0 4 100 100 2005 99 5 98 1 93 8 86 1 99 2 97 8 97 3 96 2 82 6 60 2 93 1 89 6 40 6 53 19 48 1 24 5 14 6 8 2 3 2 2009
197. 1 5SD FGR 60 AGA 120 pH Apgar score 2010 FGR 1 7 2 29 3 19 4 4 5 1 39 1 5 2338 321g 409 O 347 Population based study 1 2 3 2 D
198. 37HSD 2011 23 6 O 305 2008 2 2010 7 28 51 25 7 1 4 780 203g 519 1
199. 4 CDH CDH 10 CDH 1 4 CDH 1 37 LHR 2 2 6 2 2 37 LHR 1 8 4 nasal CPAP 3 40 3 4 37 LHR 0 93 3 ECMO 1 24 ECMO
200. 1 1 1 100 ABR 6 4 67 CMV DNA 1 VGCV CMV DNA ABR CMV DNA ll HI 402 O 317 CCMV CCMV CCMV
201. 153 15 34 TCD APCD 95 T18 34 TCD APCD TCD T18 APCD T18 51 TCD 1 56xGA 12 20 R 0 98 APCD 0 98x GA 9 65 R 0 98 GA T18 TCD TCD T18 1 25xGA 6 23 R 0 91 TCD T18 TCD p lt 0 001 T18 APCD APCD T18 0 52xGA 2 32 R 0 78 APCD T18 APCD p 0 001 TCD T18 y TCD y TCD 0 37xGA 7 11 APCD T18 y APCD y APCD 0 42xGA 7 33 y APCD 0 42 y TCD 0 37 T18 43 19 TCD APCD 3 9 T18 TCD APCD APCD T18
202. 200 GR GRz GR GC GC O 304 AGA 2 D 9 LCMSMS AGA
203. MRI MRI 26 27 3 31 2458g Apgarscore5 8 3 17 micro colon MRI caliber change
204. NOx NOx 47 2 O 311 VLBWI FT4 LT4 LT4 2007 4 2009 12 VLBWI FT4 lt 0 8 ng d1 TSH gt 10 IU ml LT45 g kg LT4 40 K 2001 18
205. 2 3 4 3D 26 24 2 SonoVCAD labor
206. 3035 5g 3151 4g 2 18 4 7 8 6 5 4 10 9kg 11 0kg 8 2kg UIU T O 328 2 2
207. DOHaD 2500g Groups GDM 2007 1 2009 12 3 75gOGTT 226 1 DM 2 a GDM 24 3 GDM 36 4 GDM 17 5 5 6 142 HbAlc HOMA 1 Index SD PIH GDM 0 82 1 29 2 42 2 95 6 1 5
208. lt a CC 385 O 251 HPV DNA 8 19 1 condyloma acuminatum 2 HPV DNA high risk type 6 high risk low risk type
209. 1 2 1 2 preliminary O 296 1 1 2 2 2
210. Caliber change PGE2 73 85 CIIPS MRI MRI 2011 23 6 O 297 A H1N1 pdm2009 2 2 2 2 2009 A H1N1pdm
211. 1 4 2010 4 2011 3 5 6cm 387 O 259 BNP brain natriuretic peptide BNP
212. D E A E 3 4 2500g 1500g 2499g 22 3 2 1297 603 O 356 2 3
213. 10 22 23 10 22 23 2 2001 2010 10 22 23 32 1 31 A B 2 31 25 6 22 6 6 0 23 25 19 6 23 3 1 2 2 5 4 3 552 5g 31 11 35 4 20 64 6 31 A B 2
214. 47 2 O 327 2006 1 2010 12 5 3000 BMI BMI 18 5 18 5 BMI lt 25 25 BMI 440 BMI17 6 30 3 2040 21 1 31 4 520 29 4 31 8 1 14 15 9 10 5 2 10 16 6 20 18 3 30 12 6 40 13 9 3 2852 8g
215. 2 38 2 0 40 13 33 3 32 9 111 12 1 111 90H 4 91 2 31 34 CDH CDH 47 2 O 287 2 3 2006 2010
216. 4 4 4 22 48 64 4 5 6 8 4 5 6 8 7 10 23 85 35 12 5 35 14 40 16 26 11 47 19 24 76 23 30 9 61 18 22 7 67 20 76 23 25 60 15 41 10 97 24 39 10 63 16 105 25 26 4 13 34 7 143 30 40 8 76 16 125 26 27 35 7 34 7 153 32 21 4 87 18 147 32 22 64 23 35 4 22 8 23 14 O 220 2003 2005 3 CP
217. 7 20 LPS MSC LPS MSCCM LPS 11 RAC radial alveolar count MBP LPS LPS MSC LPS MSCCM LPS LPS
218. O 302 QOL 10 3 Cayman Chemical r2 0 39
219. 2 3 9 2 9 9 2003 2005 100 50 23 3952 3 CP 3 MR K DQ 70 OR 95 959 CI 1 CP 2732 382 CFP 2350 CP 9 41 19
220. B 3 3 1 1 66 5 8 3 5 12 p 0 33 24 p 0 040 36 p 0 045 2010 1 6 8 2011 1 0 MRSA ICD NICU MRSA
221. RDS 1 3 2011 23 6 O 201 HFO vs CV HFO severe IVH
222. nested PCR RNA 6 RNA 5 IgG 7 7 IgM 0 34 MR 5 O 300 Na LCD LCD Na LCD
223. RIAC 125 Apgar score 1 5 30 62 4 SD 1 465454g 6 72 2 8 1 1 8 RIAC SpO2 44 48 63 GE 67 26 9 30 48 31 65 RIAC SpO2 19 23 33 RIAC 30 RIAC N DPAP RIAC 30 RIAC
224. VTE 9 24 5 5000 17500 x2 134 7 21 1 QOL O 250 2
225. 123 2009 4 2010 12 21 1220 13 18 21 45X 13T7 18 T 44 21 TT 54 45X 18 123 10 19 NT NB TR DV Micro FA FHR SUA 13 T 7 NT 71 NT 5 79mm NB43 TR71 DV43 Micro29 FHR178bpm SUA14 18 T 44 NT 98 NT 6 93mm NB75 TR52 DV75 Micro73 FA82 FHR160bpm SUA36 21 T 54 NT 94 NT 5 90mm NB89 TR74 DV 52 2 Micro9 FA81 5 FHR163bpm SUA2 45X18
226. 3 ES FGR 30 ES FGR 47 2 O 231 2 2 2006 1 2010 4 12mgx2im 27 32 AGA 70 TTTS 1 7 23 1
227. 56 1 2 3 4 2 2SD A B 22 34 38 5 1 2 1814 237g SD 2 9 0 5SD SD 2 9 0 8 SD 1 6 0 7 269 63g 1 A 49 20 29 B 7 5 A B 1 22 3 2 5 2 3 9 2 4 12 0 4 2 SGA SGA
228. CMV IgG 5 2 2 0 CMV IgM CMV 3 MRI AABR GCV GCV 2011 23 6 O 313 B
229. NICU NICU5 20 21 1 2 3 4 2 20 21 2133 458 21 5 248 11 6 92 4 3 1147 53 8 458 21 5 4 0 4 0 1 9 0 8 2 1 2 1 45 2 1 25 1 2 49 2 3 NICU 3 0
230. 2 52 3
231. 2902 10 254 118 FGR PIH 61 PIH 3 FGR PIH FGR ll HI 406 O 333
232. DPT 0 2ml NICU GCU DPT O 324 GDM NGT GDM overt diabetes OD high risk GDM HRGDM GCDM OD HRGDM 2008 1 2010 6 75gOGTT
233. p 0 580 0 695 5 lt 7 O 342 NST CTG 2006 2008 1576 NST CTG 3 long contraction wave LCW LCW fetal deceleration 2 LCW LCW deceleration 1 28 41 2 oxytocin prolonged deceleration 10
234. 17 9 143 73 87 45 173 89 3 115 59 22 28 6 2 7 23 21 7 5 23 24 34 2 13 38 25 6 7 2 30 26 6 3 2 32 27 13 3 23 28 4 8 2 42 lt 400g 50 1 2 400 499g 9 1 11 500 599g 31 9 29 600 699g 16 7 7 42 700 799g 19 4 7 36 800 899g 7 5 3 40 900 999g 2 9 1 35 24 24 3 IUGR p 0 05 OR 6 6 959 CI 2 8 15 9 G 0 05 OR 4 0 95 CI 1 5 10 8 p 0 05 OR 6 6 95 CI 1 9 23 8 O 224
235. 2 GRo GR GRg GC GR GC GR GRg GR lt GR 2005 11 2009 2 467 295 172 GR PCR ELISA 444 GRa100 GR 63 49 GAPDH100 GRa GR
236. K K 1867 325 542 DQ 85 2 15 3 SD 86 0 13 9 3 K 508 1 186 2 322 NDI CP MR DQ VLBW 3 O 222 2003 2005 3 3 1 2 3 9 2003 2005 VLBW 2003 2005 8209
237. RA14 Air 14d 14 02 14d RA 21 Air 21d 02 Air 21d 49 9 0O2 14d Air 14d 02 Air 21d 02 14d CD31 gSMA CLD
238. 1 93 8 269 9 253 2 1 7 9 34 2 1 8 2 9 3 2011 23 6 O 321 PI 2
239. NT 100 NT 9 27mm NB6 TR72 DV 50 11 Micro6 FA81 FHR180bpm SUA28 NT 13T1 18T1 NT 6 NT 13 18 21T 45X TR DV 13T 45X FHR 18T NB Micro 21T NB FA 391 O 275 1 2 27
240. 17 17 100 17 17 100 7 17 41 5 17 29 5 17 29 4 17 24 2 17 12 1 17 6 16 17 94 DORV 7 DORV VSD6 VSD 2 CoA1 FGR trisomy18 trisomy18 6 3 1 3 0 24 1 8 2 3 3 1 5 6 1 4 10 29 10 20 6 20 1
241. 2 20 3 6 S epidermidis 29 MRS 20 S aureus 18 MRSA 6 1 PI 1 2000 O 322 2 2 2
242. 2 36 1 12 22 13 8 2 25 PIH1 1 610 335g 7 987689g PIH 2 9 8 1 10 3 339 9 PIH 2011 23 6 O 257
243. B mode Dual Doppler a V EUB 7500 Preirus a V 3 2 2 5 2 HV DAo HV DAo SVC AAo a V 2011 23
244. BPD C 1 7 14 BPD 873 114 vs 494111pg ml P 0 009 BPD P 0 005 post surfactant era BPD fibrosis BPD BAL C 2011 23 6 O 209 2 3 ZEEP zero PEEP
245. GDM GDM gt 1 5SD 2006 4 2010 1 75gOGTT 195 40 71 GDM 80 88 GDM te lt O R 4 6 GDM Je 36 15 36 19 36
246. VLBW 20 1 2 MDS 25 37 6 23 4 ASD 25 58 2 21 8 one way ANOVA VLBW 36 9 13 7 28 92 8 1014 2285 2g ASD p 0 001 VLBW p lt 0 001 VLBW p 0 001 MDS ASD p 0 001 ASD VLBW p lt 0 001 VLBW MDS ASD VLBW ASD MDS
247. 2 3 1 44 46XX 2 5 6 7 cm Testosterone T 254 5 ng dl Estradiol E2 58 7 pg ml 2 20 46XX 4 1 6 18 14 T 569 7 E2 40 3 3 24 46XX 3 12
248. 2D lt 3D 3D 2011 23 6 O 265 2 3 2 3 2 CDH 8 9 CDH FETO
249. 5 CLD CLD i CLD NICU 1 2 CLD 3 Sp0z 4 CLD 1 2 CLD 3 Sp02 4
250. A 20 64 5 16 4 A 23 3 1 1 6 5 3 9 542 0g B 11 35 5 9 2 B 23 4 1 3 4 5 5 1 571 6g 2 A 5 25 0 B 6 54 5 2 A B 22 23 O 230 30
251. C G B GBS GBS GBS 2008 5 2010 4 2 GBS 36 0 12 36 17 PCG ABPC AMPC CVA PIPC CTM CTRX CPR CZOP CFPM CDTR PAPM MEPM CAM CLDM VCM TFLX LVFX MIC CLSI GBS 69 36 595 44 16 36 119 4 2 1 1 ABPC CTX
252. 8 47 R 27 29 30 32 RDS DPAP 27 29 1 9 vs R 21 RDS I 66 79 vs R 95 2 1 44 4 vs R 85 7 1 44 7 vs R 85 7 I 2 7 3 7 vs R 5 0 3 3 DPAP 1 30 7 18 3Hvs R 31 6 16 6 I 41 820Hvs R 39 512 2 R 8 14 A 9 15 B 12 A 3 32 8HYvs B 6 3 3 3 30 32 14 ys R 26 30 7 8
253. cyclooxygenase COX ibuprofen SD 300350g buprofen 100mg kg I S randomize PEEP 0 PIP 29cmHzO 90 FiO 0 21 1 S 90 PIP 29 8 3 4 vs 33 7 2 4 cmHzO 0 520 27 vs 0 26 0 06 ml cmHzO 5 33 0 69 vs 7 10 0 61 PGEz PGIz S TNFa IL 1 IL 6 NF xB
254. 2 1 53 2 1 2 36 17 9 MoM miRNA hsa miR 520b 520f 520c 3p 520b 1 00 2 47 0 01 1 51 2 54 0 02 520f 1 00 1 85 0 01 1 89 4 23 4 23 0 02 520c 3p 1 00 1 84 0 01 1 31 2 95 0 01 Mann Whitney p 0 05 miRNA O 270 Trisomy18
255. 33 28 14 19 73 7 28 32 4 12 33 3 3 12 25 0 33 21 55 38 1 19 55 34 5 10 55 18 2 1 55 1 8 3 55 5 5 33 20 4 040 0 50 1 AS 1 1 5 20 25 0 2 7 20 35 0 3 8 20 40 0 5 AS 1 1 2 5 40 0 4 AS 1 1 3 5
256. 373 O 203 1 2 H22 006 CLD 280 194 280 69 3 16 194 8
257. 69 8 1 4 2009 1 41 29 2009 5 1 1 CMV O 318 PMX DHP 8
258. CHD 106 B 231 CHD A B 12 22 12 12 16 22 14 9 11 4 CHD A CHD 89 FGR 14 11 36 CHD 2010 CHD 49 A 25 B 24 CHD A 17 2010 34 7 2 2 22 14 12 22
259. D 1 LHR observed expected LHR 0 ELHR 32 p 0 04 0 E LHR O 288 modified McGoon index MGI postductal CDH 2002 6 2010 12 CDH23 CDH2
260. GDM 36 15 17 20 GDM 10 MD 7 GDM GDM MD GDM oN O 326 HI International Association of Diabetes and Pregnancy Study
261. NO 1 NO in vitro NO 20ppm IMV PEEP5cmHzO RR30 PIP10 30cmHz0 FiOs 21 60 100 1 2 HFO Servoy PIP 10cmHzO 50ppm 30cmHzO 30ppm 3 NO 20 2ppm Servoi 3 0 5L min NO 4L min NO NO 2011 23 6 O 361 2 9 201
262. SiPAP BiPhasic 8L min 3L min T High 1 0s Rate 10bpm RiOz 0 4 27 28C 30C 32C 34C 37 33 35mg L 0 2C 0 5mg L 399C 34C 37mg L 0 5 0 5 1 0mg L SiPAP 37C 39C O 364 ME 2
263. 1 2 pH BE 10 4 pH pH7 18 2011 23 6 O 345 JA 2009 2010 2 34
264. 12 4 3 0 1 16 8 Bochdalek 1 10 4 A 4 38 119 D HFO NO D A 2 6 D 1 NRFS D 1 A 28 5 D 20 3 0 02 A D 3 liver up Lung to headratio LHR 1 4
265. B Bishop sore O 338 3D 7 36 26 SonoVCAD labor Sonography based Volume Computer Aided Display 1
266. GBS 7 356 GBS GBS 40 GBS 72 GBS 2 114 AMPC GBS GBS 1 GBS GBS GBS GBS 2 1 GBS 114 1 GBS O 314 B 8 7 Lancefield A B
267. 1 1 1 4 12 5 X 2 Rubinstein Taybi syndrome1 8 1 8 1 5 80 36 165 2 2 8 9 6 5 57 19 93 1 96 3 2 3 15 ll HI 392 O 277 59
268. 207 vs 2874 12 4 vs 8 1 p 0 049 0 5 vs 1 1 0 5 vs 0 9 K DQ 83 vs 85 DQ lt 70 14 8 vs 14 0 18 2 vs 15 1 NDI 26 8 vs 21 7 3 1 CLD PDA p lt 0 05 PLBWI 360 184 176 2 IVH 12 5 vs10 7 PVL 7 6 vs6 8 CLD 27 1 vs35 2 9 2 vs15 9 PDA
269. 3 DORV 1 2 6 25 6 5 5 3 2 4 4 2 1 1 14 4 4 6 4 47 2 O 279 1 2 2 CHD CHD 2005 1 2010 12 CHD CHD 125 A
270. 38 1 2876g Apgar score 6 1 7 5 NPPV 33 P7OX2p 1 20 26 CCHS 53 8 2 0 60 75 116 132 NPPV 5 CCHS 1 24 NPPV
271. lt CAM WBC 30062vs16972 L 88 2vs61 1 68 8s29 4 IVH 29 4vs0 BPD 31 3vs37 5 CLD 20 0vs12 5 CAM WBC CRP CAM CAM O 234 5 2 2 2 20
272. 7 4 57 4 4 100 4 36 3 Pallister Killian LT O 1 CDH LT 0 1 O 290 Trans umbilical approach CDH
273. 8 51 9 30 16 10 6 23 4 5 2 47 2 O 351 NICU 1 2 3 9 9
274. A CP 19 OR 95 CI 1 22 4 OR 1 81 1 95 2 09 3 12 95 CI 1 3 OR 0 35 0 36 0 45 2 MR 2454 382 MR 2072 MR 14 47 26 B MR 26 OR 95 CI 1 3 OR 2 05 2 19 2 65 959 CI 1 4 OR 0 38 0 39 0 40 0 43 3 0 HI 378 O 221 2003 2005 3 2
275. O 293 1 2 CRP 2006 1 2010 12 222 21 7
276. PN 20 0 11 173 4 0 2 46 100ml kg day 14 5 8 56 30 5 2 165 PN 8 36 4 PN 30 6 27 3 30 8 36 4 3 1mg dl 1 7 6 5 AST ALT 100mg d 11 50 15 68 2 5 22 7 1 2 ELBW AFD PN 7 ll HI 396
277. WBC4200 mcl RS 160 80 PICU AZM EM 23 403 O 323 NICU GCU DPT 0 2ml IO 2 ICT 3 9 3 3 DPT 0 5ml DPT 0 2ml DPT 0 2ml
278. 24 3 35 5 1330g 698g 2595g MRI K 18 MRI MRI 18 MRI 18 MRI MRI PVL knl 1
279. 55 3 4 75 3 2 ECMO 1 1 1 2 1 3 4 CDH LHR LHR CDH O 286 2 2 2 9 ECMO 2002
280. 6 6vs6 3 tt ir 8 1 vs7 3 31 19vs30 34 74 2vs57 29 121vs126 ELBWI TVH PVL ELBWI 2011 23 6 O 225 28 Preterm PROM 3 Preterm PROM PPROM
281. 7 4 B NO O 362 1 2 D D 2 100
282. 9 O 226 32 2 2 D 33
283. CLD 22 4kg CLD VIQ IQ 87 9 PIQ IQ 83 4 FIQ IQ 84 1 non CLD VIQ 101 7 PIQ 93 3 FIQ 97 1 CLD CLD 14 58 ADHD non CLD 4 17 ADHD PDD CLD CLD 9 lt CLD 0 HN 374 O 205 2 2000 3 CLD 1995
284. Colitis UC 2005 1 2010 12 6 UC 35 CD 22 UC CD IUC 33 2 32 1 25 10 29 6 UC 510g 682g 38 6 3057g 2 2 LICD 17 5 33 0 15 7 10 12 CD 7 2 NRFS 2 1 36
285. F p 28 29 70 intervention 1 N p 4 19 SpO0z 40 3 S 4ch 11 21 4ch 9 40 F s ductal shock DIC N s 24 41 ductal shock 6 DIC 47 4ch pickup ll HI 394 O 285
286. LPS L control C 22 56 HE Ng C Vg 56 C L 56 L Ng C C vs L 84 16 7 vs 33 3 9 mean SE mm3 p 0 05 Vg C vs L 30 4 2 vs 44 5 7 mean SE x10 5mm3 p lt 0 05 LPS 47 2 O 215
287. cystic PVL 2006 HFO CV conventional ventilation HFO CV 2001 2010 NICU 27 72 CV CHFO 72 p 0 05 mean SD HFO 0 vsCV 27 25 2 1 1vs24 7 1 2 730 210vs699 119g Apgar score 5 6 60 3vs7 00 3 RDS 83 vs74 3 32 4 1 8vs26 5 1 7mmHg HEFO 97 vs48 volume expander 17 vs3 7 severe IVH 23 vs0 cystic PVL 23 vs3 7 17 vs3 7 HFO
288. mu O 238 Key age DQ IQ 2009 2010
289. 0 A 5 B 3 A 0 2 B 1 3 2 A 22 24 47 2 O 295
290. 0 8 NO A NO FOS _H NO ECL 88A BB 1 2 3 4 1 A 15 B 30 360 2 A B NO 3 8ppm B 4 A
291. 15 Apgar score Apgar score 7 AGA 3 FGR pH p 0 17 pH 7 15 p 0 16 3 O 346 2007 2010 4 318 1 1 3 86 28 28 28 32 28 32 33
292. 2009 25 6 CHD FGR CHD O 280 Dual Doppler SVC AAo a V Dual Doppler HV DAo 16 39 6
293. 372 O 197 Bi level nasal CPAP Infant flow nasal SiPAP Bilevel nasal CPAP Bilevel nasal CPAP DPAP 30 31 4 SiPAP Bidlevel nasal CPAP Biphasic mode Ti 1 0sec Rate20 Weaning Rate10 monophasic mode CPAP high 6 7cmHzO CPAP low 4cmHzO 4 CPAP DPAP Age matched control 8 SiPAP 40 4 37 4 DPAP 62 529 9 CPAP 126 55 113 146 SiPAP
294. 397 O 299 MR JA 20 30 20 30 EIA IgG 2 0 31 9 3 MR128 0 5mL 3 5 RNA P E1 cDNA RT PCR RT PCR
295. 6 O 281 STIC FGR 2 STTC 3 2 19 25 FGR 3 vessels trachea view 32 3 CTAR60 plastering peak systolic velocity 2 9m sec
296. 75 BMI 948 BMI lt 18 5 18 5 25 25 lt 8kg 8kg 12kg 12kg BMI lt BMI BMI BMI 25 25
297. 8 121 117 3 0 25 EA 0 2 2 xg ml 0 19 6 EA 2mg 20g EA CSEA 3 4 5 pH 154 Le p 0 001 lt 7 2
298. CS 0 300 0 179mmHsg 20 23 26 8 95 45 525 126 765 3 3 4 17 1 6 5
299. HC 1 sLLS 2 sLLS HC TAF TAF 7 MV 54 sLLS 53 24 44 sLLS 30 sLLS sLLS 24 17 71 HC HC HC 4mg kg TAF TAF TAE IL 6 2MG sLLS sLLS 7 TAF IL 6 2MG sLLS sLLS HC 17 HC 2 TAF TAF 4 TAF IL 6 2MG sLLS MV
300. NICU p 0 01 EFW 600g AUC 0 894 28 AUC 0 833 Z 3 5SD AUC 0 684 UA AUC 0 689 AUC 0 672 MCA Z O 334
301. cter jenuni lgG 717mg dl 1124mg q lg Campylobacter GBS B CVID CVID Ig Ig CVID 50 40 383 O 243 7 7 1 50 7 39 3 3
302. munodeficiency 1 Common variable immunodeficiency CVID CVID 28 21 22 24 RCC 26 IgG 1mg dl CVID B CD4 rT y Ig 28 27 5 34 Ig IgG 500mg 35 GBS ABPC SBT6g day 38 0 1990g Ap9 10 Campyloba
303. proach 395 O 291 4 1 2 D 2 4 1 41 2 3046g

【はじめに】新生児の上気道は構造的に

Contents

Download Pdf Manuals

Related Search

Related Contents

【はじめに】 新生児の上気道は構造的に

Contents

Download Pdf Manuals

Related Search

Related Contents

【はじめに】新生児の上気道は構造的に